China Factory Supply High Quality Fluconazole Powder CAS. 86386-73-4 99% Purity, Find details about China Fluconazole, CAS. 86386-73-4 from Factory Supply High Quality Fluconazole Powder CAS. 86386-73-4 99% Purity
Product name | Fluconazole |
CAS no. | 86386-73-4 |
Molecular Formula | C13H12F2N6O |
Molecular Weight | 306.27 |
Brand Name | Senwayer |
Fluconazole is used to prevent and treat a variety of fungal and yeast infections. It belongs to a class of drugs called azole antifungals. It works by stopping the growth of certain types of fungus.
Fluconazole is an antifungal medication used for a number of fungal infections. This includes candidiasis, blastomycosis, coccidiodomycosis, cryptococcosis, histoplasmosis, dermatophytosis, and pityriasis versicolor. It is also used to prevent candidiasis in those who are at high risk such as following organ transplantation, low birth weight babies, and those with low blood neutrophil counts.
1. Fluconazole is indicated in the treatment of febrile neutropenia when fungal infections are suspected or proven.
2. Fluconazole is indicated in nonimmunocompromised patients for the treatment of onychomycosis caused by tinea unguium, Trichophyton species and Candida species.
3. Fluconazole is indicated for the treatment and suppression of cryptococcal meningitis.
4. Fluconazole is indicated in the treatment of pulmonary and disseminated coccidioidomycosis caused by Coccidioides immitis.
5. Fluconazole is indicated in the treatment of vulvovaginal candidiasis caused by Candida species.
6. Fluconazole is indicated for the treatment of serious infections, including peritonitis, pneumonia, and urinary tract infections, caused by susceptible Candida species.
7. Fluconazole is also indicated for the treatment of systemic infections caused by Candida species in neonates.
8. Fluconazole is indicated for the treatment of esophageal and oropharyngeal candidiasis (thrush) caused by Candida species.
9. Fluconazole is indicated for the prophylaxis of candidiasis in patients undergoing bone marrow transplant who receive cytotoxic chemotherapy and/or radiation therapy.